Sentry LLC’s Medtronic MDT Stock Holding History

Sentry LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Hold	13,604	–	–	0.38%	35
2025 Q4	$1.31M	Hold	13,604	–	–	0.36%	32
2025 Q3	$1.3M	Hold	13,604	–	–	0.32%	35
2025 Q2	$1.19M	Hold	13,604	–	–	0.24%	35
2025 Q1	$1.22M	Buy	13,604 +1,358	+11%	+$122K	0.24%	34
2024 Q4	$978K	Sell	12,246 -1,358	-10%	-$118K	0.19%	40
2024 Q3	$1.22M	Hold	13,604	–	–	0.24%	34
2024 Q2	$1.07M	Hold	13,604	–	–	0.2%	35
2024 Q1	$1.19M	Sell	13,604 -4	-0%	-$341	0.22%	32
2023 Q4	$1.12M	Sell	13,608 -36	-0.3%	-$2.74K	0.24%	30
2023 Q3	$1.07M	Hold	13,644	–	–	0.23%	34
2023 Q2	$1.2M	Hold	13,644	–	–	0.26%	32
2023 Q1	$1.1M	Buy	+13,644	New	+$1.11M	0.26%	36

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sentry LLC's MDT Position: Q1 2026 in Review

Sentry LLC held its Medtronic (MDT) position steady in Q1 2026 at 13,604 shares worth $1.18M. The position accounts for 0.38% of the portfolio, ranked #35.

Sentry LLC first reported a position in MDT in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.31M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Sentry LLC held 13,604 shares of Medtronic worth $1.18M as of Q1 2026.
Sentry LLC left its Medtronic share count unchanged in Q1 2026.
Medtronic made up 0.38% of Sentry LLC's portfolio in Q1 2026, its #35 holding.
Sentry LLC first reported a position in Medtronic in Q1 2023 and has held it in 13 quarters since.
Sentry LLC's Medtronic position peaked at $1.31M in Q4 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sentry LLC's 13F filing for Q1 2026, filed 23 Apr 2026.